Injected antibodies provide long-term protection against HIV Trial results show extended protection against HIV in monkeys treated with monoclonal antibodies.…
Nivolumab should be standard for head and neck cancer Treatment with nivolumab improves survival in patients with head and neck squamous-cell carcinoma compared with chemotherapy, study finds.…
Personalised dosing technology shows promise for transplant patients A medicine platform that calculates a patient’s ideal dose is effective and has the potential to be used in other therapeutic areas, research shows.…
Engineered protein shows promise for HIV vaccine development Researchers create protein that can bind to broadly neutralising antibodies that can target HIV infection.…
Omalizumab reduces colds in children with asthma Children treated with omalizumab had 27% fewer colds then those treated with guideline-based care.…
Delve into the complex and interesting world of the immune system ‘Immunity’, by William E Paul. Pp xiii+260 £19.50. Baltimore: John Hopkins University Press; 2016. 978 1 421 41801 8…
Caplacizumab speeds up resolution of rare thrombotic disorder Study suggests novel therapy could prevent short and long-term organ damage associated with aTTP.…
Monoclonal antibody shows promise for chronic sinusitis Study shows dupilumab therapy improves smell, sinus volume and inspiratory flow in patients with polyps.…
High-dose vitamin D supplementation has beneficial immune effects in MS Researchers say further studies will help determine efficacy of vitamin D3 in multiple sclerosis.…
Cancer metastasis could be prevented with immune-blocking strategy Researchers find immune system involved in metastasis-boosting microenvironment in mice.…
